Skip to main content
Clinical Trials/JPRN-jRCTs032220329
JPRN-jRCTs032220329
Recruiting
Phase 3

The effect of short term intensive cognitive training using repetitive transcranial magnetic stimulation for mild cognitive impairment - The effect of intensive cognitive training using rTMS for MCI

Takakura Tomokazu0 sites30 target enrollmentSeptember 12, 2022

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Takakura Tomokazu
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Takakura Tomokazu

Eligibility Criteria

Inclusion Criteria

  • 1\.Be aware of forgetfulness.
  • 2\.Housework and activities of daily living are generally normal.
  • 3\.Age more than or equal to 60 years and less tha 80 years.
  • 4\.Those who can go to the hospital according to the test protocol.
  • 5\.Written informed consent to participate in this study.

Exclusion Criteria

  • 1\.Under treatment for epilepsy/depression/mania/ schizophrenia.
  • 2\.Who have a cardiac pacemaker, implantable defibrillator, metal near the stimulation site (cochlear implant, magnetic clip, deep brain stimulation / vagus nerve stimulation), or implantable drug solution pump.
  • 3\. Severe heart disease:unstable angina,short\-term myocardial infarction from onset, decompensated congestive heart failure, acute pulmonary heart, uncontrolled arrhythmia, severe aortic stenosis, active Myocarditis, endocarditis, etc.
  • 4\. Uncontrolled hypertension
  • 5\. Acute systemic illness or fever
  • 6\. Complications of recent pulmonary embolism, acute cor pulmonale, and severe pulmonary hypertension
  • 7\. Complication of severe hepatic / renal dysfunction
  • 8\. Severe orthopedic complications
  • 9\. Severe cognitive impairment (MMSE\-J less tha or equal to 20/30\), complications of severe mental illness
  • 10\. Other metabolic disorders (such as acute thyroiditis)

Outcomes

Primary Outcomes

Not specified

Similar Trials